SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs quarterly earnings beat and raised outlook, led by strong U.S. commercial AI growth, are driving attention. Bulls view the results as evidence of durable demand, while bears argue the growth is already priced in and question valuation and slower contract-value growth; the weak share reaction also reflects broader pressure on tech stocks.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples quarterly earnings beat estimates, but shares sold off as traders focused on margin pressure from rising memory costs, the forward outlook, and weaker-than-expected China, iPad, and wearables results. The reaction has split the community between dip buyers citing strong iPhone sales and bears questioning growth and valuation.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells all-stock agreement to acquire Lumentum is driving attention, with traders criticizing the dilution, price and long closing timeline as the stock sells off. Others argue the deal strengthens Marvells position in AI data-center optical connectivity and could pay off over the longer term.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is drawing attention after a sharp selloff alongside semiconductor stocks following Intels disappointing report, with its upcoming earnings and guidance viewed as a test of whether Intels weakness signals broader chip-market trouble or is company-specific. Traders are split between expecting more pressure if results or guidance disappoint and viewing the pullback as excessive, with some betting AMD can outperform Intel and rebound.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL trial reached its prespecified 80th event, triggering final analysis ahead of expected topline results and putting the binary AML readout at the center of discussion. The selloff has fueled debate over profit-taking and risk reduction versus speculation about a negative leak or short pressure, while traders remain divided on whether GPS will succeed.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles planned stock and bond offerings to fund its AI and data-center buildout are driving attention as shares sell off. Traders are split between viewing the financing as dilutive and evidence of debt and cash-flow risk, and arguing it was already disclosed and supports long-term growth.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

DIA drew attention as the Dow held up better than tech-heavy indexes amid concern over AI spending and valuations, with traders debating whether the markets bounce could last and many continuing to favor shorts. Lower oil on hopes for U.S.-Iran diplomacy also featured in the broader market discussion.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

A report that Usona has submitted an FDA application for psilocybin in major depression is raising competition concerns and weighing on Helus Pharma. Traders debate whether HLP003s adjunctive approach and potential advantages can distinguish it, with many looking to the upcoming Phase 3 results for clarity.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergents Q3 results and reduced full-year outlook are driving discussion, with traders focused on weak revenue, declining NARCAN sales and delayed or uncertain government orders. Bears question the turnaround and debt outlook, while bulls point to cost cuts and potential future CYFENDUS replenishment as offsets.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisks sharp selloff despite strong earnings and guidance is being tied to weakness across memory stocks after rival Kioxia issued a cautious outlook, alongside broader concerns about memory pricing and the AI trade. Bulls point to strong data-center demand and long-term supply commitments, while bears focus on the sectors momentum and the risk that earnings strength may not prevent further declines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ATOS Please share your price and date estimates based on each scenario:
1- Russel 2000 Inclusion  5-8$   (4th of June)
2- P2   15-25  (Monday 7th to Wednesday 9th)
3- Partnership and BO 30+ (Flag day to middle of July before option Expirations, most of HF bought for this date )
4- Short Squeeze 60+ (anytime on the way)

C0caine

Rafael Hernández Aragón

Phillip

JPTR

Lewis

Cj Waters

Michael

Ashton Plowe

GayJ

Alex Dowling

Cris Pantras

Sand

Jason

Kersten

I just wanted to re-share this,  it&#39;s happening now

StockTwits Web

ORDR Terminal

Atossa Therapeutics Inc

 Please share your price and date estimates based on each scenario:
1- Russel 2000 Inclusion  5-8$   (4th of June)
2- P2   15-25  (Monday 7th to Wednesday 9th)
3- Partnership and BO 30+ (Flag day to middle of July before option Expirations, most of HF bought for this date )
4- Short Squeeze 60+ (anytime on the way)

StockTwits for iOS

Jerry

@shkspr think I’m blocked from you on yahoo bro not sure what’s up with that?

 think I’m blocked from you on yahoo bro not sure what’s up with that?

Huggs

@SgtGunner be sure my friend, as long as your name is not Logistic or James, you are not blocked. lol

 be sure my friend, as long as your name is not Logistic or James, you are not blocked. lol

@shkspr I wanted to say 7 to 20 and i slept after that misprint not 2 at all..Morning I see chaos.

 I wanted to say 7 to 20 and i slept after that misprint not 2 at all..Morning I see chaos.